e-ISSN: Pending
Negative / Null Result ReportOpen accessSpecialties of internal medicine

Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories

Sanam Loghavi; Dawen Sui; Peng Wei; Guillermo Garcia-Manero; Sherry Pierce; Mark J. Routbort; Elias J. Jabbour; Naveen Pemmaraju · 2018 · Blood Advances

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Abstract: The 2017 revision of the World Health Organization (WHO) classification includes substantial changes to the subclassification of chronic myelomonocytic leukemia (CMML): (1) a 3-tiered blast-based scheme including a novel “CMML-0” category replacing a 2-tiered system in place since 2001 and (2) 2 CMML subtypes, myelodysplastic (MDS-CMML) and myeloproliferative (MP-CMML), based on a white blood cell count cutoff of 13 × 109/L. The clinical utility of this subclassification scheme, particularly the expansion of blast-based subgroups, has not been validated. In this study, a large single

Abstract by Sanam Loghavi; Dawen Sui; Peng Wei; Guillermo Garcia-Manero; Sherry Pierce; Mark J. Routbort; Elias J. Jabbour; Naveen Pemmaraju, Blood Advances (2018) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ · DOI 10.1182/bloodadvances.2018019224